-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RRjbf4L8534BR53viq5k7jrQ7gbdunE7Hpd+tZVoLFZaj/cUDDq+C8AVB7Y+Y0Y+ bi4pq9+JxeW7BBfA6XyJXQ== 0001089355-03-000244.txt : 20030416 0001089355-03-000244.hdr.sgml : 20030416 20030415180546 ACCESSION NUMBER: 0001089355-03-000244 CONFORMED SUBMISSION TYPE: 10KSB/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20021231 FILED AS OF DATE: 20030416 FILER: COMPANY DATA: COMPANY CONFORMED NAME: POLYMER RESEARCH CORP OF AMERICA CENTRAL INDEX KEY: 0000079424 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 112023495 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10KSB/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-14119 FILM NUMBER: 03651484 BUSINESS ADDRESS: STREET 1: 2186 MILL AVE CITY: BROOKLYN STATE: NY ZIP: 11234 BUSINESS PHONE: 7184444300 MAIL ADDRESS: STREET 1: 2186 MILL AVE CITY: BROOKLYN STATE: NY ZIP: 11234 10KSB/A 1 polymer10ksba8232.txt AMENDED 10KSB SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM 10-KSB [X] ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2002 [ ] TRANSITION REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file No. 0-14119-NY POLYMER RESEARCH CORP. OF AMERICA --------------------------------- (Name of small business issuer in its charter) ---------------------------------------------- NEW YORK 11-2023495 - ------------------------------- ------------------------------- (State or other jurisdiction of (IRS Employer Identification incorporation or organization) Number) 2186 Mill Avenue, Brooklyn, NY 11234 - --------------------------------------- --------- (Address of principal executive offices) (Zip Code) Issuer's telephone number including area code: (718) 444-4300 -------------- Securities registered pursuant to Section 12(b) of the Act: NONE Securities registered pursuant to Section 12(g) of the Act: Common Stock, $.01 par value Check whether the issuer: (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No ------- ------- Check if there is no disclosure of delinquent filers in response to Item 405 of Regulation S-B contained in this form, and no disclosure will be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-KSB or any amendment to this Form 10-KSB. X . State issuers' revenues for its most recent fiscal year - $2,127,457 The aggregate market value of voting stock held by non-affiliates of the Registrant at March 31, 2003 was approximately $1,195,696 based on the last sale price of such stock. As of March 31, 2003, the Registrant had 2,053,644 shares of Common Stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE NONE SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. POLYMER RESEARCH CORP. OF AMERICA POLYMER RESEARCH CORP. OF AMERICA --------------------------------- (Registrant) By /s/ Carl Horowitz Date April 15, 2003 -------------------- ----------------- CARL HOROWITZ, President and Chief Executive Officer In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated /s/ Carl Horowitz Director April 15, 2003 - --------------------------------- ----------------- Carl Horowitz Date /s/ Irene Horowitz Director April 15, 2003 - -------------------------------- ----------------- Irene Horowitz Date /s/John Ryan Director April 15, 2003 - -------------------------------- ----------------- John Ryan Date /s/Alice J. Horowitz Director April 15, 2003 - -------------------------------- ----------------- Alice J. Horowitz Date /s/Jascha J. Gurevitz Director April 15, 2003 - -------------------------------- ----------------- Jascha J. Gurevitz Date /s/Boris Jody Director April 15, 2003 - -------------------------------- ----------------- Boris Jody Date /s/Dr. Mohan Sanduja Director April 15, 2003 - -------------------------------- ----------------- Dr. Mohan Sanduja PhD Date /s/Terry J. Wolfgang Director April 15, 2003 - -------------------------------- ----------------- Terry J. Wolfgang Date I, Carl Horowitz, certify that: 1. I have reviewed this annual report on Form 10-KSB of Polymer Research Corp. of America; 2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report; 3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report; 4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and I have: a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared; b) evaluated the effectiveness of the registrant's disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the "Evaluation Date"); and c) presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date; 5. I have disclosed, based on my most recent evaluation, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions): a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant's ability to record, process, summarize and report financial data and have identified for the registrant's auditors any material weaknesses in internal controls; and b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls; and 6. I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. April 15, 2003 /s/ Carl Horowitz ---------------------- Carl Horowitz Chief Executive Officer and Chief Financial Officer EX-99.1 3 ex99-1.txt Exhibit 99.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C.ss.1350 Solely for the purposes of complying with 18 U.S.C. 1350, I, the undersigned Chief Executive Officer and Chief Financial Officer of Polymer research Corp. of America (the "Company"), hereby certify, to the best of my knowledge, that the Annual Report on Form 10-KSB of the Company for the year ended December 31, 2002 ( the "Report") fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. April 15, 2003 /s/ Carl Horowitz ------------------------ Carl Horowitz Chief Executive Officer and Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----